Mixtures of Wild-type and a Pathogenic (E22G) Form of Aβ40 in Vitro Accumulate Protofibrils, Including Amyloid Pores
- 26 September 2003
- journal article
- Published by Elsevier BV in Journal of Molecular Biology
- Vol. 332 (4), 795-808
- https://doi.org/10.1016/s0022-2836(03)00927-6
Abstract
No abstract availableKeywords
This publication has 61 references indexed in Scilit:
- Annular α-Synuclein Protofibrils Are Produced When Spherical Protofibrils Are Incubated in Solution or Bound to Brain-Derived MembranesBiochemistry, 2002
- Charge states rather than propensity for β‐structure determine enhanced fibrillogenesis in wild‐type Alzheimer's β‐amyloid peptide compared to E22Q Dutch mutantProtein Science, 2002
- Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseasesNature, 2002
- Protofibrils, the unifying toxic molecule of neurodegenerative disorders?Nature Neuroscience, 2001
- The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Aβ protofibril formationNature Neuroscience, 2001
- Vesicle Permeabilization by Protofibrillar α-Synuclein: Implications for the Pathogenesis and Treatment of Parkinson's DiseaseBiochemistry, 2001
- The Molecular Chaperone αB-crystallin Enhances Amyloid β NeurotoxicityBiochemical and Biophysical Research Communications, 1999
- Mutations in the Transmembrane Domain of APP Altering γ-Secretase SpecificityBiochemistry, 1997
- α-1-Antichymotrypsin interaction with Aβ (1–40) inhibits fibril formation but does not affect the peptide toxicityNeuroscience Letters, 1996
- SPIDER and WEB: Processing and Visualization of Images in 3D Electron Microscopy and Related FieldsJournal of Structural Biology, 1996